Peptide Drug Conjugates (PDCs) present major growth opportunities in oncology and beyond, triggered by innovations in peptide chemistry, enhanced targeting, and reduced systemic toxicity. With a ...

Pfizer has abandoned work on a PD-L1-targeting drug that was being tested in patients with various cancers. | Pfizer has ...

WALTHAM, Mass., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Conjugate Group, a leading provider of Flexible Drug Development™ services, is proud to announce a strategic expansion of its service portfolio by ...

Patients with advanced platinum-resistant ovarian cancer whose disease had progressed on standard therapy experienced ...

By Daniella Parra Callio Therapeutics presented preclinical data at AACR that supports the first dual-payload antibody drug ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from STRIDE-8, a Phase 3 trial evaluating CAPVAXIVE™ (Pneumococcal ...

Five of seven serotypes in the pneumococcal conjugate vaccine, introduced for infants in the United States in 2000, are responsible for most penicillin-resistant infections. We examined the effect of ...

Prior to the advent of antimicrobial therapy, case fatality rates for typhoid fever exceeded 20% in many areas, since untreated disease led to complications such as intestinal perforation. In 1948, ...